Brinzolamide 布林佐胺
CAS 138890-62-7 MFCD08067749
化学结构图
SMILES:
化学属性
| Mol. Formula | C12H21N3O5S3 |
|---|---|
| Mol. Weight | 383.51 |
| Melting Point | 130-134 |
别名和识别编码
| Chemical Name | Brinzolamide |
|---|---|
| Synonym | (5R)-5-Ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2?6,9-dithia-3-azabicyclo[4.3.0]nona-7,10-diene-8-sulfonamide (R)- 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide AL 4862 |
| MDL Number | MFCD08067749 |
| Beilstein Registry Number | 9651552 |
| Chemical Name Translation | 布林佐胺 |
| PubChem Substance ID | 329825236 |
分类
- {SNA} B, Bioactive Small Molecule Alphabetical Index, 生物活性小分子, 细胞生物学
- {SNA} B, Bioactive Small Molecules, Cell Biology
相关文献及参考
- [2]. Silver, L.H., Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study Group. Surv Ophthalmol, 2000. 44 Suppl 2: p. S147-53.
- [1]. DeSantis, L., Preclinical overview of brinzolamide. Surv Ophthalmol, 2000. 44 Suppl 2: p. S119-29.
- [1]. DeSantis, L., Preclinical overview of brinzolamide. Surv Ophthalmol, 2000. 44 Suppl 2: p. S119-29.
- [2]. Silver, L.H., Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study Group. Surv Ophthalmol, 2000. 44 Suppl 2: p. S147-53.
安全信息
GHS Symbol
京ICP备2020036287号